Delivery Order SPE2DX22D0030-SPE2D826F0CC9

The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $113,624 to AmerisourceBergen Drug Corp on December 1, 2025, with completion targeted for December 2, 2025. This firm fixed-price, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999 through December 2026. The work will be performed at the company's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, supplies a comprehensive portfolio of pharmaceutical products and medical supplies to support military and federal healthcare systems, including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains.

This delivery order exemplifies AmerisourceBergen's role as a critical vendor within the DLA's pharmaceutical supply chain, which supports the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The award reflects the company's demonstrated capability to meet federal procurement requirements through competitive bidding and its established track record of fulfilling medical supply needs ranging from small transactions to substantial orders exceeding $45,000. As a prime vendor under the global pharmaceutical support vehicle, AmerisourceBergen continues to serve as a key supplier for military healthcare programs worldwide, delivering essential pharmaceutical commodities to support operational readiness and personnel healthcare needs.